Protein (1)Antibody (2)
Launched (3)
Hendra virus (1)Mouse (2)
His Tag (1)- (2)
Unconjugated (3)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|---|
HEN-MY2109 | HEK293 | Monoclonal Anti-Hendra virus G glycoprotein Antibody, Human IgG1 (2D9) (MALS verified) | ||||
HEN-MY2110 | HEK293 | Monoclonal Anti-Hendra virus G glycoprotein Antibody, Human IgG1 (6A6) (MALS verified) | ||||
GLN-H52H3 | Hendra virus | HEK293 | Hendra virus Glycoprotein, His Tag (MALS verified) | ![]() |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| CXCR5 Modified EGFR Chimeric Antigen Receptor Autologous T Cell Therapy | Phase 1 Clinical | Second Affiliated Hospital Of Guangzhou Medical University | Carcinoma, Non-Small-Cell Lung | Details |

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)
メールアドレス
order.jp@acrobiosystems.com
アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8




